Attention-deficit/hyperactivity disorder (ADHD) is diagnosed through a comprehensive clinical evaluation, not through a single brain scan. SPECT imaging has nevertheless been used in research and in some complex clinical situations to study patterns of brain blood flow associated with attention, impulse control, and executive function. Understanding what a SPECT scan can contribute—and where its limits lie—can help patients, families, and clinicians make more informed decisions.
What is a SPECT scan?
Single-photon emission computed tomography, or SPECT, is a nuclear medicine imaging method. A small amount of radioactive tracer is injected into the bloodstream, and a camera rotates around the head to create three-dimensional images showing the tracer’s distribution. These images provide information about regional cerebral blood flow at the time of the scan.
Preparation varies by clinical setting. Patients may be asked to avoid caffeine, remain calm before imaging, or temporarily withhold stimulant medication when clinically appropriate. Medication changes should only be made under the direction of the treating clinician. The resulting images may be reviewed visually and, in some settings, compared with reference or normative databases by professionals familiar with brain imaging and neuropsychiatric assessment.
What SPECT research suggests about ADHD
Studies of SPECT imaging in ADHD have reported differences in blood-flow patterns in brain regions involved in attention and self-regulation. Findings often discussed in the research include reduced perfusion in parts of the frontal brain, including areas involved in planning, working memory, sustained attention, and impulse control.
Research has also examined the basal ganglia and parts of the limbic system. These structures are involved in movement, motivation, reward processing, and emotional regulation. Differences in these networks may help researchers explore why some people experience distractibility, forgetfulness, difficulty organising tasks, or problems with inhibitory control.
These are group-level research patterns, not a universal brain signature for every person with ADHD. Results can vary according to age, symptom profile, medication status, sleep, recent mental activity, and co-occurring conditions. A scan is also a snapshot of brain perfusion at one point in time, rather than a complete measure of a person’s abilities or behaviour.
Can SPECT diagnose ADHD?
No. SPECT is not a stand-alone diagnostic test for ADHD. Diagnosis requires a clinical assessment that considers developmental history, symptoms across settings, functional impairment, behavioural observations, and standardised rating scales where appropriate. Clinicians also consider other explanations for attention or behaviour changes, including mood difficulties, anxiety, sleep problems, learning challenges, neurological conditions, and the effects of trauma or medication.
An abnormal or unusual perfusion pattern cannot, by itself, confirm ADHD. Likewise, an imaging result that does not match commonly described research patterns does not rule ADHD out. The clinical picture remains central.
When might SPECT be considered?
SPECT is more commonly discussed as an adjunctive tool than as a routine part of ADHD assessment. In selected, complicated cases, imaging may provide additional context when symptoms are severe, atypical, difficult to explain, or not responding as expected to treatment. It may also prompt further evaluation for another or additional neurological or psychiatric condition, although the scan does not replace targeted diagnostic testing.
In research settings, SPECT has been used to investigate possible ADHD subtypes and to study physiological changes associated with treatments. Some clinicians and researchers have also examined before-and-after scans when evaluating interventions. Such comparisons may be informative in a research or carefully monitored clinical context, but a change in an image does not automatically prove that a treatment has improved everyday functioning.
Limitations and risks
- Radiation exposure: SPECT uses a radioactive tracer, so potential benefits and risks should be discussed, especially when considering imaging for children.
- Variable interpretation: Equipment, image-processing methods, reference databases, and the expertise of the interpreting professional can affect results.
- Possible misleading findings: False-positive and false-negative interpretations are possible, particularly when images are considered without full clinical context.
- Practical barriers: Cost, insurance coverage, availability, and access to clinicians experienced in neuropsychiatric imaging may limit usefulness.
- Limited scope: SPECT shows information about blood-flow patterns; it does not directly measure every aspect of attention, behaviour, learning, or daily functioning.
How to discuss a SPECT result
Anyone considering SPECT for ADHD should ask why the scan is being recommended, what question it is intended to answer, whether the result would change treatment, and what alternatives are available. Results should be reviewed with a qualified healthcare professional who can relate the images to symptoms, developmental history, functional difficulties, medications, and other medical or mental-health factors.
SPECT research has contributed to understanding the biological systems involved in ADHD, particularly networks related to attention and executive control. In clinical care, however, its most appropriate role is generally supportive and contextual. A thorough assessment—not an isolated scan—should guide diagnosis and treatment decisions.
Dr. Jonathon Preston is a respected mental health specialist dedicated to helping individuals overcome challenges. With advanced training in psychology and decades of experience in the mental health field.